Recurrent carpal tunnel syndrome (CTS) is a condition where symptoms such as numbness, tingling, and weakness in the hand persist or return after initial treatment. While common causes include repetitive strain or incomplete surgical release, it is important for clinicians to consider less common underlying causes, such as amyloidosis.

Understanding Amyloidosis

Amyloidosis is a rare group of diseases characterized by the abnormal deposition of amyloid proteins in tissues and organs. When amyloid deposits occur in the peripheral nerves, they can lead to nerve compression and dysfunction, mimicking or contributing to conditions like carpal tunnel syndrome.

Patients with amyloidosis may develop CTS due to amyloid deposits in the transverse carpal ligament or surrounding tissues. This can cause persistent symptoms even after standard treatments such as carpal tunnel release surgery. Recognizing this link is crucial for accurate diagnosis and management.

Clinical Clues to Consider

  • Recurrent symptoms despite prior surgical intervention
  • Presence of systemic symptoms such as weight loss, fatigue, or swelling
  • History of other organ involvement, like kidney or heart issues
  • Unusual nerve conduction study findings

Diagnostic Approach

Diagnosis of amyloidosis requires a high index of suspicion. Confirmatory tests include tissue biopsy with Congo red staining showing apple-green birefringence under polarized light. Additionally, advanced imaging and laboratory tests can help identify systemic amyloidosis.

Implications for Treatment

Identifying amyloidosis as the underlying cause alters the treatment approach. Management may involve systemic therapies such as chemotherapy or targeted treatments for amyloid removal, alongside addressing nerve compression. Early diagnosis can improve patient outcomes and prevent further organ damage.